RECRO PHARMA INC (REPH) Stock Cash Flow
NASDAQ:REPH - Nasdaq - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.37M | -27.50M | -18.63M | -79.72M | -50.08M | |||
| Depreciation Amortization | 7.57M | 8.54M | 8.40M | 7.85M | 7.44M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 17.64M | -1.69M | |||
| Change In Working Capital | 5.68M | 11.65M | -10.52M | -6.08M | 440.00K | |||
| Interest Paid | 7.24M | 13.95M | 14.40M | 8.13M | 5.34M | |||
| Taxes Paid | N/A | N/A | 0.00 | 0.00 | 470.00K | |||
| Other non cash items | 8.98M | 15.37M | -4.75M | 17.20M | 26.84M | |||
| OPERATING CASH FLOW | 10.86M | 8.07M | -25.50M | -43.12M | -17.04M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.29M | -7.60M | -8.34M | -10.61M | -6.69M | |||
| Other Investing Activity | -24.00M | N/A | -1.52M | 3.53M | -3.62M | |||
| INVESTING CASH FLOW | -29.29M | -7.60M | -9.86M | -7.08M | -10.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -10.10M | -5.77M | 43.60M | 10.00M | 28.23M | |||
| Stock Issued/Repurchased | 32.10M | 11.37M | -13.00M | 18.78M | 50.00K | |||
| Other Financing Activity | -2.11M | -1.45M | -14.61M | -1.05M | -4.43M | |||
| FINANCING CASH FLOW | 19.89M | 4.15M | 15.99M | 27.73M | 23.86M | |||
| CHANGE IN CASH | 1.46M | 4.62M | -19.37M | -22.47M | -3.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 10.86M | 8.07M | -25.50M | -43.12M | -17.04M | |||
| Capital Expenditure | -5.29M | -7.60M | -8.34M | -10.61M | -6.69M | |||
| FREE CASH FLOW | 5.57M | 470.00K | -33.84M | -53.73M | -23.73M | |||
All data in USD